Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double-Blind, Placebo-Controlled Study of Rifampicin in Multiple System Atrophy

NCT01287221 is registered in ClinicalTrials.gov with Phillip Low as lead sponsor.

NCT NCT01287221
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01287221 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double-Blind, Placebo-Controlled Study of Rifampicin in Multiple System Atrophy
Lead sponsor
Phillip Low
Phase
Phase 3
Overall status
Terminated
Start date
March 31, 2011
Completion date
January 31, 2013
Enrollment
100 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

multiple system atrophy